Amedisys Gross Profit 2010-2024 | AMED

Amedisys gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Amedisys Annual Gross Profit
(Millions of US $)
2023 $991
2022 $963
2021 $994
2020 $921
2019 $805
2018 $670
2017 $608
2016 $585
2015 $555
2014 $513
2013 $531
2012 $630
2011 $668
2010 $807
2009 $779
Amedisys Quarterly Gross Profit
(Millions of US $)
2024-03-31 $250
2023-12-31 $249
2023-09-30 $245
2023-06-30 $256
2023-03-31 $241
2022-12-31 $245
2022-09-30 $236
2022-06-30 $242
2022-03-31 $240
2021-12-31 $242
2021-09-30 $243
2021-06-30 $260
2021-03-31 $249
2020-12-31 $251
2020-09-30 $251
2020-06-30 $213
2020-03-31 $206
2019-12-31 $205
2019-09-30 $206
2019-06-30 $202
2019-03-31 $192
2018-12-31 $172
2018-09-30 $168
2018-06-30 $169
2018-03-31 $161
2017-12-31 $159
2017-09-30 $146
2017-06-30 $154
2017-03-31 $148
2016-12-31 $134
2016-09-30 $149
2016-06-30 $154
2016-03-31 $147
2015-12-31 $146
2015-09-30 $140
2015-06-30 $138
2015-03-31 $131
2014-12-31 $129
2014-09-30 $130
2014-06-30 $132
2014-03-31 $122
2013-12-31 $124
2013-09-30 $126
2013-06-30 $138
2013-03-31 $143
2012-12-31 $150
2012-09-30 $157
2012-06-30 $160
2012-03-31 $162
2011-12-31 $149
2011-09-30 $168
2011-06-30 $179
2011-03-31 $172
2010-12-31 $187
2010-09-30 $198
2010-06-30 $213
2010-03-31 $209
2009-12-31 $198
2009-09-30 $205
2009-06-30 $199
2009-03-31 $177
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.162B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.759B 16.29
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Chemed (CHE) United States $8.450B 26.19
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00